✦ LIBER ✦

Implications of the Organization to Assess Strategies for Ischemic Syndromes–2 (OASIS–2) study and the results in the context of other trials

✍ Scribed by Keith A.A Fox

Book ID: 113980774
Publisher: Elsevier Science
Year: 1999
Tongue: English
Weight: 148 KB
Volume: 84
Category: Article
ISSN: 0002-9149
DOI: 10.1016/s0002-9149(99)00380-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Design, baseline characteristics, and pr

Design, baseline characteristics, and preliminary clinical results of the Organization to Assess Strategies for Ischemic Syndromes–2 (OASIS–2) trial

✍ Salim Yusuf 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 129 KB

Comparison of the anticoagulant intensit

Comparison of the anticoagulant intensities of fondaparinux and enoxaparin in the organization to assess strategies in acute ischemic syndromes (OASIS)-5 trial

✍ J. A. M. ANDERSON; J. HIRSH; S. YUSUF; M. JOHNSTON; R. AFZAL; S. R. MEHTA; K. A. 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 140 KB

The organization to assess strategies fo

The organization to assess strategies for ischemic syndromes (OASIS) pilot study: evaluation of acute and long-term therapies for patients with acute coronary syndromes without ST elevation

✍ Sonia S Anand 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 191 KB

Impact of Diabetes on Long-Term Prognosi

Impact of Diabetes on Long-Term Prognosis in Patients With Unstable Angina and Non-Q-Wave Myocardial Infarction : Results of the OASIS (Organization to Assess Strategies for Ischemic Syndromes) Registry

✍ Malmberg, K.; Yusuf, S.; Gerstein, H. C.; Brown, J.; Zhao, F.; Hunt, D.; Piegas, 📂 Article 📅 2000 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 358 KB

Efficacy and safety of fondaparinux in p

Efficacy and safety of fondaparinux in patients with ST-segment elevation myocardial infarction across the age spectrum. Results from the Organization for the Assessment of Strategies for Ischemic Syndromes 6 (OASIS-6) trial

✍ Tjeerd E. van Rees Vellinga; Ron J.G. Peters; Salim Yusuf; Rizwan Afzal; Susan C 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 199 KB

Efficacy and Safety of Fondaparinux Vers

Efficacy and Safety of Fondaparinux Versus Enoxaparin in Patients With Acute Coronary Syndromes Treated With Glycoprotein IIb/IIIa Inhibitors or Thienopyridines: Results From the OASIS 5 (Fifth Organization to Assess Strategies in Ischemic Syndromes) Trial

✍ Sanjit S. Jolly; David P. Faxon; Keith A.A. Fox; Rizwan Afzal; William E. Boden; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 847 KB